Latest News in the pharma Industry

All

Innova Biosciences introduces Magnetic Conjugation Kit

Innova Biosciences introduces Magnetic Conjugation Kit

21 Feb 2017

New kit enables covalent conjugation of antibodies and proteins to magnetic particles.

Read more 
Companies harness AI power to improve medication adherence

Companies harness AI power to improve medication adherence

20 Feb 2018

Unique sensor technology tracks inhalation profiles and technique.

Read more 
Recipharm completes strategic acquisition in India

Recipharm completes strategic acquisition in India

20 Feb 2017

The acquired business is now known as Recipharm Pharmaservices Private Ltd.

Read more 
Russian Government drive to increase domestic manufacturing fuelling growth at CPhI Russia

Russian Government drive to increase domestic manufacturing fuelling growth at CPhI Russia

20 Feb 2017

Distributors, API manufacturers, and machinery providers seeing high demand across Russia and CIS.

Read more 
New data in Crohn’s disease patients shows similar efficacy and safety profiles for Inflectra and Remicade

New data in Crohn’s disease patients shows similar efficacy and safety profiles for Inflectra and Remicade

20 Feb 2017

Trial data further supports the existing clinical profile of CT-P13 in inflammatory bowel disease.

Read more 
Sartorius and EMBL join forces to offer advanced training and science education

Sartorius and EMBL join forces to offer advanced training and science education

19 Feb 2017

Sartorius is offering its expertise to enhance scientific education and practice.

Read more 
Phase II study supports potential for Genentech’s Tecentriq plus Avastin for people with mRCC

Phase II study supports potential for Genentech’s Tecentriq plus Avastin for people with mRCC

19 Feb 2017

Study showed that people whose disease expressed PD-L1 and were treated with Tecentriq plus Avastin had a 36% reduction in the risk of their disease worsening

Read more 
Vectura achieves £9 million royalty cap from GSK Ellipta products

Vectura achieves £9 million royalty cap from GSK Ellipta products

19 Feb 2017

Company achieves the £9 million calendar year royalty cap on net sales of Ellipta products a year earlier than previously guided.

Read more 
Turbofer: innovative formulation for iron deficiency

Turbofer: innovative formulation for iron deficiency

16 Feb 2017

NTC Pharma expands its product portfolio with a new food supplement containing iron pyrophosphate microencapsulated in liposomal form, Turbofer orosoluble granules.

Read more 
FDA expands approval of Spiriva Respimat inhalation spray

FDA expands approval of Spiriva Respimat inhalation spray

16 Feb 2017

Steroid-free Spiriva Respimat now approved as asthma treatment for age 6 and older.

Read more 
Catalent completes Accucaps acquisition

Catalent completes Accucaps acquisition

16 Feb 2017

Expands softgel development and manufacturing capabilities and capacity.

Read more 
FDA accepts BLA for Mylan and Biocon's proposed biosimilar pegfilgrastim for review

FDA accepts BLA for Mylan and Biocon's proposed biosimilar pegfilgrastim for review

16 Feb 2017

The proposed biosimilar to Neulasta is used to reduce the duration of neutropenia and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy in certain types of cancer.

Read more